Insulin regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase-dependent pathway

FASEB Journal

Volumn 14, Issue 7, 2000, Pages 1015-1022

  Solano, Daniela C ^a   Sironi, Marita ^a   Bonfini, Claudia ^a   Solerte, S Bruno ^b   Govoni, Stefano ^b,c   Racchi, Marco ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

Author keywords

Alzheimer's disease; PI3 kinase; Signal transduction; secretase

Indexed keywords

AMYLOID PRECURSOR PROTEIN; INSULIN; PHOSPHATIDYLINOSITOL 3 KINASE;

ALZHEIMER DISEASE; ARTICLE; HUMAN; HUMAN CELL; NERVE DEGENERATION; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN PROCESSING; PROTEIN SECRETION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 0034012017     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.14.7.1015     Document Type: Article

References (46)

1. Weidemann, A., Konig, G., Bunke, D., Fischer, P., Salbaum, J. M., Masters, C. L., and Beyreuther, K. (1989) Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 57, 115-126
2. Sisodia, S. S. Koo, E. H., Beyreuther, K., Unterberk, A., and Price, D. L. (1990) Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing. Science 248, 492-495
3. Anderson, J. P., Esch, F. S., Keim, P. S., Sambamurti, K., Lieberburg, J., and Robakis, N. K. (1991) Exact cleavage site of Alzheimer amyloid precursor in neuronal PC-12 cells. Neurosci. Lett. 128, 126-8
4. Racchi, M., and Govoni, S. (1999) Rationalizing a pharmacological intervention on the amyloid precursor protein metabolism. Trends Pharmacol. Sci. 20, 418-423
5. Mills, J., and Reiner, P. B. (1999) Regulation of amyloid precursor protein cleavage. J. Neurochem. 72, 443-460
6. Le Blanc, A. C., Koutroumanis, M., and Goodyer, C. G. (1998) Protein kinase C activation increases release of secreted amyloid precursor protein without decreasing Aβ production in human primary neuron cultures. J. Neurosci. 18, 2907-2913
7. Mattson, M. P. (1997) Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77, 1081-132
8. Buxbaum, J. D., Ruefli, A. A., Parker C. A., Cypess, A. M., and Greengard, P. (1994) Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner. Proc. Natl. Acad. Sci. USA. 91, 4489-4493
9. Racchi, M., Ianna, P., Binetti, G., Trabucchi, M., and Govoni, S. (1998) Bradykinin-induced amyloid precursor protein secretion, a protein kinase C-independent mechanism that is not altered in fibroblasts from patients with sporadic Alzheimer's disease. Biochem. J. 330, 1271-1275
10. Hoyer, S. (1996) Oxidative metabolism deficiencies in brains of patients with Alzheimer's disease. Ada Neurol. Scand. 165, 18-24
11. Chandrasekaran, K., Hatanpaa, K., Brady, D. R., and Rapoport S. I. (1996) Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease. Exp. Neurol. 142, 80-88
12. Blass, J. P., Sheu, K. F., Piacentini, S., and Sorbi, S. (1997) Inherent abnormalities in oxidative metabolism in Alzheimer's disease: interaction with vascular abnormalities. Ann. New York Acad. Sci. 826, 382-385
13. Munch, G., Schinzel, R., Loske, C., Wong, A., Durany, N., Li, J. J., Vlassara, H., Smith, M. A., Perry, G., and Riederer, P. (1998) Alzheimer's disease-synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts. J. Neural Transmission. 105, 439-461
14. Hoyer, S., Nitsch, R., and Oesterreich, K. (1991) Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: a cross-sectional comparison against advanced late-onset and incipient earl-onset cases. J. Neural Transm. 3, 1-14
15. Fukuyama, H., Ogawa, M., Yamauchi, H., Yamaguchi, S., Kimura, J., Yonekura, Y., and Konishi, J. (1994) Altered cerebral energy metabolism in Alzheimer's disease. A PET study. J. Nuclear Med. 35, 1-6
16. Gabuzda, D., Busciglio, J., Chen, L. B., Matsudaira, P., and Yankner, B. A. (1994) Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J. Biol. Chem. 269, 13623-13628
17. Gasparini, L., Racchi, M., Benussi, L., Curti, D., Binetti, G., Bianchetti, A., Trabucchi, M., and Govoni, S. (1997) Effect of energy shortage and oxidative stress on amyloid precursor protein metabolism in COS cells. Neurosci. Lett. 231, 113-117
18. Gasparini, L., Racchi, M., Binetti, G., Trabucchi, M., Solerte, S. B., Alkon, D., Etcheberrigaray, R., Gibson, G., Blass, J., Paoletti, R., and Govoni, S. (1998) Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease FASEB J. 12, 17-34
19. Peterson, C., and Goldman, J. E. (1986) Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. Proc. Natl. Acad. Sci. USA 83, 2758-2762
20. Sims, N. R. Finegan, J. M., and Blass, J. P. (1987) Altered metabolic properties of cultured skin fibroblasts in Alzheimer's disease. Ann. Neurol. 21, 451-457
21. Parker, W. D., Jr., Mahr, N. J., Filley, C. M., Parks, J. K., Hughes, D., Young, D. A., and Cullum, C. M. (1994) Reduced platelet cytochrome c oxidase activity in Alzheimer's disease Neurology. 44, 1086-1090
22. Davis, R. E., Miller, S., Herrnstadt, C., Ghosh, S. S., Fahy, E., Shinobu, L. A., Galasko, D., Thai, L. J., Beal, M. F., Howel'l, N., and Parker, W. D., Jr. (1997) Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA 94, 4526-4531
23. Curti, D., Rognoni, F., Gasparini, L., Cattaneo, A., Paolillo, M., Racchi, M., Zani, L., Bianchetti, A., Trabucchi, M., Bergamaschi, S., and Govoni, S. (1997) Oxidative metabolism in cultured fibroblasts derived from sporadic Alzheimer's disease (AD) patients. Neurosci. Lett. 236, 13-16
24. Gasparini, L., Benussi, L., Bianchetti, A., Binetti, G., Curti, D., Govoni, S., Moraschi, S., Racchi, M., and Trabucchi, M. (1999) Energy metabolism inhibition impairs amyloid precursor protein secretion from Alzheimer's fibroblasts Neurosci. Lett. 263, 197-200
25. Bergamaschi, S., Binetti, G., Govoni, S., Wetsel, W. C., Battaini, F., Trabucchi, M., Bianchetti, A., and Racchi, M. (1995) Defective phorbol ester-stimulated secretion of beta-amyloid precursor protein from Alzheimer's disease fibroblasts. Neurosci. Lett. 201, 1-5
26. Lahiri, D. K., Lewis, S., and Farlow, M. R. (1994) Tacrine alters the secretion of the beta-amyloid precursor protein in cell lines. J. Neurosci. Res. 37, 777-787
27. Parvathy, S., Hussain, I., Karran, E. H., Turner, A. J., and Hooper N. M. (1998) Alzheimer's amyloid precursor protein alpha-secretase is inhibited by hydroxamic acid-based zinc metalloprotease inhibitors: similarities to the angiotensin converting enzyme secretase. Biochemistry 37, 1680-1685
28. Toullec, D., Pianetti, P., Coste, H., Bellevergue, P., Grand-Perret, T., Ajakane, M., Baudet, V., Boissin, P., Boursier, E., Loriolle, F., et al. (1991) The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266, 15771-15781
29. Mills, J., Laurent Charest, D., Lam, F., Beyreuther, K., Ida, N., Pelech, S. L., and Reiner, P. B. (1997) Regulation of amyloid precursor protein catabolism involves the mitogen-activated protein kinase signal transduction pathway. J. Neurosci. 17, 9415-9422
30. Desdouits-Magnen, J., Desdouits, F., Takeda, S., Syu, J., Saltiel, A R., Buxbaum, J. D., Czernik, A. J ., Nairn, A. C., and Greengard, P. (1998) Regulation of secretion of Alzheimer amyloid precursor protein by the mitogen-activated protein kinase cascade. J. Neurochem. 70, 524-530
31. Haring, R., Fisher, A., Marciano, D., Pittel, Z., Kloog, Y., Zuckerman, A., Eshhar, N., and Heldman, E. (1998) Mitogen-activated protein kinase-dependent and protein kinase C-dependent pathways link the m1 muscarinic receptor to beta-amyloid precursor protein secretion. J. Neurochem. 71, 2094-2103
32. Brunn, G. J., Williams, J. Sabers, C., Wiederrecht, G., Lawrence, J. C., Jr., and Abraham, R. T. (1996) Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J. 15, 5256-5267,
33. Vlahos, C. J., Matter, W. F., Hui, K. Y., and Brown, R. F. (1994) A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholmyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269, 5241-5248
34. Erikson, R. L. (1991) Structure, expression, and regulation of protein kinases involved in the phosphorylation of ribosomal protein S6. J. Biol. Chem. 266, 6007-6010
35. Sturgill, T. W., and Wu, J. (1991) Recent progress in characterization of protein kinase cascades for phosphorylation of ribosomal protein S6. Biochim. Biophys. Acta 1092, 350-357
36. Slack, B. E., Breu, J., Muchnicki, L., and Wurtman, R. J. (1997) Rapid stimulation of amyloid precursor protein release by epidermal growth factor: role of protein kinase C. Biochem. J. 327, 245-249
37. White, M. F. (1998) The IRS-signalling system: a network of docking proteins that mediate insulin action. Mol. Cell. Biochem. 182, 3-11
38. Shepherd, P. R., Withers, D. J and Siddle, K. (1998) Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling. Biochem. J. 333, 471-490
39. Proud, C. G., and Denton, R. M. (1997) Molecular mechanisms for the control of translation by insulin. Biochem. J. 328, 329-341
40. Welsh, G.I., Stokes, C. M., Wang, X., Sakaue, H., Ogawa, W., Kasuga, M., and Proud, C. G. (1997) Activation of translation initiation factor eIF2B by insulin requires phosphatidyl inositol 3-kinase. FEBS Lett. 410, 418-22,
41. Clarke, J. F., Young, P. W., Yonezawa, K., Kasuga, M., and Holman, G. D.,. (1994) Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin. Biochem. J. 300, 631-635
42. Okada, T., Kawano, Y., Sakakibara, T., Hazeki, O., and Ui, M. (1994) Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. J. Biol. Chem. 269, 3568-3573
43. Jess, T. J., Belham, C. M., Thomson, F. J., Scott, P. H., Plevin, R. J., and Gould, G. W. (1996) Phosphatidylinositol 3′-kinase, but not p70 ribosomal S6 kinase, is involved in membrane protein recycling: wortmannin inhibits glucose transport and downregulates cell-surface transferrin receptor numbers independently of any effect on fluid-phase endocytosis in fibroblasts. Cell. Signal. 8, 297-304
44. De Camilli, P., Emr, S. D., McPherson, P. S., and Novick, P. (1996) Phosphoinositides as regulators in membrane traffic. Science 271, 1533-1539
45. Takadera, T., Sakura, N., Mohri, T., and Hashimoto, T. (1993) Toxic effect of a beta amyloid peptide (β22-35) on the hippocampal neuron and its prevention. Neurosci. Lett. 161, 41-44
46. Dore, S., Kar, S., and Quirion, R. (1997) Insulin-like growth factor I protects and rescues hippocampal neurons against beta amyloid and human amylin induced toxicity. Proc. Natl. Acad. Sci. USA 94, 4772-4777